GLP-2 and leptin are associated with hyperinsulinemia in non-obese female migraineurs

Cephalalgia. 2010 Nov;30(11):1366-74. doi: 10.1177/0333102410364674. Epub 2010 Mar 26.

Abstract

Objective: Impaired insulin metabolism has been implicated in migraine. However, to date only some putative effects, especially regarding the involvement of adipocytokines and glucagon-like peptides (GLPs), have been described. The aim of the present study was to investigate adipocytokines and GLPs in non-obese female migraineurs.

Methods: Various parameters of the insulin metabolism and body measurements were determined in 84 non-obese female subjects.

Results: We found highly significantly increased insulin levels with an odds ratio of 10.62 for migraine. Leptin and GLP-2 levels were also increased and correlated with insulin. Logistic regression analysis of leptin and GLP-2 revealed odds ratios of 3.79 and 4.26 for migraine, respectively, when comparing the lowest with the highest quartile of the test variable in the complete study cohort.

Discussion: We show that non-obese female migraineurs suffer from hyperinsulinemia, which is associated with elevated leptin and GLP-2 levels. Increased leptin and GLP-2 are risk factors for migraine. Our data suggest that migraine is associated with a higher risk for insulin resistance and its clinical consequences.

MeSH terms

  • Adult
  • Body Mass Index
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Glucagon-Like Peptide 2 / blood*
  • Humans
  • Hyperinsulinism / complications*
  • Hyperinsulinism / metabolism*
  • Leptin / blood*
  • Migraine Disorders / complications*
  • Migraine Disorders / metabolism*
  • Risk Factors

Substances

  • Glucagon-Like Peptide 2
  • Leptin